Serum amyloid A in the assessment of early inflammatory arthritis

Journal of Rheumatology

Volumn 27, Issue 1, 2000, Pages 58-63

  Cunnane, Gaye ^a,c   Grehan, Sharon ^b,d   Geoghegan, Susan ^b,d   Mccormack, Christine ^b,d   Shields, Denis ^b,d   Whitehead, Alexander S ^b,d   Bresnihan, Barry ^a   Fitzgerald, Oliver ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute phase response; C reactive protein; Early inflammatory arthritis; Rheumatoid arthritis; Serum amyloid A

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; SERUM AMYLOID A;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; AUTOLYSIS; DISEASE ACTIVITY; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOREGULATION; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MONITORING; PHAGOCYTOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; ARTHRITIS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; SERUM AMYLOID A PROTEIN; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0033970903     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kushner I. The acute phase response: An overview, Methods Enzymol 1988;163:373-83.
2. Stadnyk A, Gauldie J. The acute phase protein response during parasitic infection. Immunol Today 1991;12:A7-12.
3. Steel DM, Whitehead AS. The major acute phase reactants: C-reaetive protein, serum amyloid P component and serum amyloid A protein, Immunol Today 1994;15:81-8.
4. Mackiewicz A, Speroff T, Ganapathi MK, Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991;146:3032-7.
5. Sipe JD. Acute phase proteins in osteoarthritis. Semin Arthritis Rheum 1995;25:75-86.
6. Larsen A. The relation of radiographic changes to serum acute phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:123-9.
7. Chambers RE, Hutton CW, Dieppe PA, Whicher JT. Comparative study of C reactive protein and serum amyloid A in experimental inflammation. Ann Rheum Dis 1991;50:677-9.
8. Maury CPJ. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sci 1985;68:233-8.
9. Pepys MB. Rheumatoid arthritis: the role of acute-phase proteins. Br J Rheumatol 1993;32(S3):1-2.
10. Brandwein SR, Medsger TA, Skinner M, Sipe JD, Rodnan GP, Cohen AS. Serum amyloid A protein concentration in progressive sclerosis. Ann Rheum Dis 1984;43:586-9.
11. Grindulis KA, Scott DL, Robinson MW, Bacon PA, McConkey B. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs. Br J Rheumatol 1985;24:158-63.
12. Chambers RE, Macfarlane DG, Whicher JT, Dieppe PA. Serum amyloid A protein concentration in rheumatoid arthritis and its role in monitoring disease activity. Ann Rheum Dis 1983;42:665-7.
13. Hartmann A, Eide TC, Fauchald P, et al. Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejection. Nephrol Dial Transplant 1997;12:161-6.
14. Mozes G, Friedman N, Shainkin-Kestenbaum R. Serum amyloid A: an extremely sensitive marker for intensity of tissue damage in trauma patients and indicator of acute response in various diseases. J Trauma 1989;29:71-4.
15. Sukenik S, Henkin J. Zimlichman S, et al. Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and noninflammatory arthritis. J Rheumatol 1988;15:942-5.
16. Hachulla E, Saile R, Parra HJ, et al. Serum amyloid A concentrations in giant cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease. Clin Exp Rheumatol 1991;9:157-63.
17. Kushner I, Jiang SL, Zhang D, Lozanski G, Samols D. Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1 ? Ann NY Acad Sci 1995;762:102-7.
18. Benditt EP, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 1977;74:4025-8.
19. Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985;21:283-7.
20. Piirainen HI, Helve AT, Tornroth T, Pettersson TE. Amyloidosis in mixed connective tissue disease. Scand J Rheumatol 1989;18:165-8.
21. Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF. The development of disability in rheumatoid arthritis. Arthritis Rheum 1986;29:494-500.
22. Dawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyle sedimentation rate reduces radiological progression. Br J Rheumatol 1986;25:44-9.
23. McCormack CC, Hobson AH, Doyle S, Jackson J, Kilty C, Whitehead AS. Generation of soluble recombinant human acute phase serum amyloid A2 (A-SAA2) protein and its use in development of a A-SAA specific ELISA. J Immunol Methods 1996;198:101-10.
24. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Veale D, Rogers S, FitzGerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994;33:133-8.
26. Ritchie DM, Boyle JA. McInnes JM, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393-406.
27. McCormack CC. Expression of human recombinant A-SAA and its use in the development of a specific ELISA [PhD thesis]. Dublin: University of Dublin, Ireland; 1996.
28. Devlin J. Cough A, Huissoon A, et al. The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. J Rheumatol 1997;24:9-13.
29. Smith JW, Colombo JL, McDonald TL. Comparison of serum amyloid A and C-reactive protein as indicators of lung inflammation in corticosteroid treated and non-corticosteroid treated cystic fibrosis patients. J Clin Lab Anal 1992;6:219-24.
30. Urieli-Shoval S. Meek RL, Hanson RH, Eriksen N, Benditt EP. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol 1994;145:650-60.
31. 2-microglobulin-like proteins. Science 1989;243:655-7.
32. Brennan FM, Field M, Chu CQ, Feldman M, Maini RN. Cytokine expression in rheumatoid arthritis. Br J Rheumatol 1991;30 Suppl 1:76-80.
33. Ganapathi MK, May LT, Schultz D. et al. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem Biophys Res Commun 1988;157:271-7.
34. Grehan S, Uhlar CM, Sim RB, Herbert J, Whitehead AS. Expression of biologically active recombinant mouse IL-1 receptor antagonist and its use in vivo to modulate aspects of the acute phase response. J Immunol 1997;159:369-78.
35. Rokita H. Loose LD. Bartle LM, Sipe JD. Synergism of interleukin 1 and interleukin 6 induces serum amyloid A production while depressing fibrinogen: a quantitative analysis. J Rheumatol 1994;21:400-5.
36. Malle E. Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 1993;102:131-46.
37. Badolato R, Wang JM, Murphy WJ, et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994;180:203-9.
38. Xu L. Badolato R. Murphy WJ, et al. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J Immunol 1995;155:1184-90.
39. Preciado-Patt L, Hershkoviz R, Fridkin M. Lider O. Serum amyloid A hinds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells. J Immunol 1996;156:1189-95.
40. Kisilevsky R. Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 1992;66:778-85.
41. Meek RL. Uricli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 1994;91:3186-90.
42. Mitchell TI, Coon CI, Brinckerhoff CE. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralised with specific antiserum. J Clin Invest 1991;87:1177-85.
43. Migita K, Kawabe Y, Tominaga M, Origuchi T, Aoyagi T, Eguchi K. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest 1998;78:535-9.